🇺🇸 FDA

Company profile · Sponsor

Chinese

Chinese PLA General Hospital

C829720 · NMPA pharma CN
Pipeline
4
Drugs
0
Patents
0

Quick answer

Chinese (C829720) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C829720
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (4)

Search pipeline →

  1. Chemotherapy drug

    Chinese

    Gastric Cancer

    phase 3 small molecule active

    1 trial

  2. adoptive immunotherapy

    Chinese

    Hepatocellular Carcinoma

    phase 3 mab completed

    1 trial

  3. anti-CD133-CAR vector-transduced T cells

    Chinese

    Liver Cancer

    phase 2 mab completed

    1 trial

  4. raltitrexed combined with apatinib

    Chinese

    Colorectal Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Chinese?

Chinese (C829720) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 4 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Chinese sponsor?

We track 4 ClinicalTrials.gov-linked programs for Chinese, including Chemotherapy drug and 3 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Chinese company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.